Related Experiment Video
Updated: Feb 4, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
[Management of transplant-associated thrombotic microangiopathy]
1Fukushima Medical University.
Abstract:
The clinical features of transplant-associated thrombotic microangiopathy (TA-TMA) include microangiopathic hemolytic anemia, consumptive thrombocytopenia, and organ dysfunction caused by thrombi in microvessels. The pathogenesis of TA-TMA is based on vascular endothelial insults caused by various factors, including chemotherapy and total-body irradiation used for transplant pre-conditioning, calcineurin inhibitors, cytokines release associated with infection, and complement factors. The incidence of TA-TMA is approximately 15-30% among allogeneic transplant patients, and the mortality rate reaches 100% in severe cases with multi-organ dysfunction. This review describes the current understanding of the pathogenesis, diagnostic criteria, and treatment strategies of this potentially lethal transplant-associated complication.
Insights
Transplant-associated thrombotic microangiopathy (TA-TMA) is a serious complication characterized by anemia, low platelets, and organ damage. This review covers its causes, diagnosis, and treatments for this potentially fatal condition.
Area of Science:
- Hematology
- Transplantation Immunology
- Oncology
Background:
- Transplant-associated thrombotic microangiopathy (TA-TMA) presents with microangiopathic hemolytic anemia, thrombocytopenia, and organ dysfunction due to microvascular thrombosis.
- Vascular endothelial damage from chemotherapy, radiation, immunosuppressants, infections, and complement activation underlies TA-TMA pathogenesis.
- TA-TMA affects 15-30% of allogeneic transplant patients, with severe cases exhibiting 100% mortality.
Purpose of the Study:
- To review the current understanding of TA-TMA pathogenesis.
- To outline diagnostic criteria for TA-TMA.
- To discuss established and emerging treatment strategies for TA-TMA.
Main Methods:
- Literature review of TA-TMA.
- Synthesis of current knowledge on TA-TMA pathogenesis.
- Analysis of diagnostic criteria and treatment options.
Main Results:
- TA-TMA is triggered by diverse insults to vascular endothelium post-transplant.
- Diagnosis relies on characteristic clinical and laboratory findings.
- Treatment strategies are evolving, addressing underlying causes and thrombotic events.
Conclusions:
- TA-TMA is a critical complication of allogeneic transplantation with significant morbidity and mortality.
- A comprehensive understanding of pathogenesis is crucial for timely diagnosis and effective management.
- Further research is needed to optimize treatment protocols and improve patient outcomes.
Related Concept Videos
Kidney Transplant III: Nursing Management
Tonsillitis II: Management
Impression Management Techniques I: Managing Appearances
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Managing Impressions
Management of Insomnia

